Literature DB >> 5944655

Use of the activated partial thromboplastin time in the control of heparin administration.

J G Lenaham, S Frye, G E Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5944655

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Expression and characterization of wild-type TFPI and the [P151L]TFPI mutant in insect cells.

Authors:  Elmar Thyzel; Sabine Siegling; Thomas Brinkmann; Knut Kleesiek; Christian Götting
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

2.  A modified whole blood partial thromboplastin test for the assessment of heparinization.

Authors:  P K Ray; D Abbott
Journal:  Can Med Assoc J       Date:  1973-06-23       Impact factor: 8.262

3.  Monitoring heparin therapy with the activated partial thromboplastin time.

Authors:  R K Stuart; A Michel
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262

4.  Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments.

Authors:  Sajid Ali; Muhammad Umair Amin; Imran Tariq; Muhammad Farhan Sohail; Muhammad Yasir Ali; Eduard Preis; Ghazala Ambreen; Shashank Reddy Pinnapireddy; Jarmila Jedelská; Jens Schäfer; Udo Bakowsky
Journal:  Int J Nanomedicine       Date:  2021-02-11

5.  Establishment and evaluation of a rat model of extracorporeal membrane oxygenation (ECMO) thrombosis using a 3D-printed mock-oxygenator.

Authors:  Nao Umei; Angela Lai; Jennifer Miller; Suji Shin; Kalliope Roberts; Saif Ai Qatarneh; Shingo Ichiba; Atsuhiro Sakamoto; Keith E Cook
Journal:  J Transl Med       Date:  2021-04-28       Impact factor: 5.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.